These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 23115085

  • 1. Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Kusuhara H, Miura M, Yasui-Furukori N, Yoshida K, Akamine Y, Yokochi M, Fukizawa S, Ikejiri K, Kanamitsu K, Uno T, Sugiyama Y.
    Drug Metab Dispos; 2013 Jan; 41(1):206-13. PubMed ID: 23115085
    [Abstract] [Full Text] [Related]

  • 2. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M, Uno T, Tateishi T, Suzuki T.
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [Abstract] [Full Text] [Related]

  • 4. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Komori H, Saito S, Kusuhara H, Tamai I, Ieiri I, Uno T, Yasui-Furukori N.
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
    [Abstract] [Full Text] [Related]

  • 5. Chiral Discrimination of P-glycoprotein in Parturient Women: Effect of Fluoxetine on Maternal-Fetal Fexofenadine Pharmacokinetics.
    Pinto L, Moreira FL, Nardotto GHB, Cavalli RC, Moisés ECD, Duarte G, Lanchote VL.
    Pharm Res; 2020 Jun 17; 37(7):131. PubMed ID: 32557079
    [Abstract] [Full Text] [Related]

  • 6. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M.
    Expert Opin Drug Metab Toxicol; 2018 Apr 17; 14(4):429-434. PubMed ID: 29635947
    [Abstract] [Full Text] [Related]

  • 7. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T, Shimizu M, Sugawara K, Tateishi T.
    Drug Metab Dispos; 2006 Nov 17; 34(11):1875-9. PubMed ID: 16928786
    [Abstract] [Full Text] [Related]

  • 8. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
    Pinto L, Bapat P, de Lima Moreira F, Lubetsky A, de Carvalho Cavalli R, Berger H, Lanchote VL, Koren G.
    Pharm Res; 2021 Apr 17; 38(4):647-655. PubMed ID: 33825113
    [Abstract] [Full Text] [Related]

  • 9. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA, Bruce MA, Haehner-Daniels BD, Hall SD.
    Clin Pharmacol Ther; 2001 Mar 17; 69(3):114-21. PubMed ID: 11240975
    [Abstract] [Full Text] [Related]

  • 10. Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers.
    Robbins DK, Castles MA, Pack DJ, Bhargava VO, Weir SJ.
    Biopharm Drug Dispos; 1998 Oct 17; 19(7):455-63. PubMed ID: 9818712
    [Abstract] [Full Text] [Related]

  • 11. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.
    Togami K, Tosaki Y, Chono S, Morimoto K, Hayasaka M, Tada H.
    J Pharm Pharmacol; 2013 Jan 17; 65(1):22-9. PubMed ID: 23215684
    [Abstract] [Full Text] [Related]

  • 12. [Determinants of the stereoselective pharmacokinetics of fexofenadine].
    Akamine Y.
    Yakugaku Zasshi; 2015 Jan 17; 135(3):473-81. PubMed ID: 25759055
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of oat3-mediated renal uptake as a mechanism for drug-drug interaction between fexofenadine and probenecid.
    Tahara H, Kusuhara H, Maeda K, Koepsell H, Fuse E, Sugiyama Y.
    Drug Metab Dispos; 2006 May 17; 34(5):743-7. PubMed ID: 16455804
    [Abstract] [Full Text] [Related]

  • 14. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
    Kim KA, Park PW, Park JY.
    Eur J Clin Pharmacol; 2009 Jun 17; 65(6):609-14. PubMed ID: 19221726
    [Abstract] [Full Text] [Related]

  • 15. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X, Knight BM, Thakker DR.
    Mol Pharm; 2011 Oct 03; 8(5):1677-86. PubMed ID: 21780830
    [Abstract] [Full Text] [Related]

  • 16. Effects of single and multiple doses of itraconazole on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M, Uno T, Sugawara K, Tateishi T.
    Br J Clin Pharmacol; 2006 Sep 03; 62(3):372-6. PubMed ID: 16796706
    [Abstract] [Full Text] [Related]

  • 17. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
    Akamine Y, Miura M, Komori H, Tamai I, Ieiri I, Yasui-Furukori N, Uno T.
    Drug Metab Pharmacokinet; 2015 Oct 03; 30(5):352-7. PubMed ID: 26213156
    [Abstract] [Full Text] [Related]

  • 18. Regional absorption of fexofenadine in rat intestine.
    MacLean C, Moenning U, Reichel A, Fricker G.
    Eur J Pharm Sci; 2010 Dec 23; 41(5):670-4. PubMed ID: 20869437
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
    Russell T, Stoltz M, Weir S.
    Clin Pharmacol Ther; 1998 Dec 23; 64(6):612-21. PubMed ID: 9871426
    [Abstract] [Full Text] [Related]

  • 20. Preclinical and clinical evidence for the collaborative transport and renal secretion of an oxazolidinone antibiotic by organic anion transporter 3 (OAT3/SLC22A8) and multidrug and toxin extrusion protein 1 (MATE1/SLC47A1).
    Lai Y, Sampson KE, Balogh LM, Brayman TG, Cox SR, Adams WJ, Kumar V, Stevens JC.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):936-44. PubMed ID: 20519552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.